Anzeige
Mehr »
Montag, 23.03.2026 - Börsentäglich über 12.000 News
Das "Next Butte?"-Setup in Montana - und es ist noch immer eine $15M-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Cision News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoSciety leads 36 MSEK funding round in Everdrone - commercialising autonomous drone service for life-saving emergency response
DoVEIDEKKE ASA: Expecting seven percent growth in 2026 and 2027
DoCAPMAN OYJ: CapMan and CAERUS enter the European infrastructure debt market
DoONCOINVENT ASA: Oncoinvent secures new patent expanding protection for Radspherin
DoCHALMERS: Direct nervous system link promises more natural leg prostheses
MiResolutions at Axfood's 2026 Annual General Meeting
MiKemira Oyj: Acquisition of own shares on March 18, 2026
MiOlvi Oyj: Share Repurchases 18.3.2026
MiSRV YHTIÖT OYJ: SRV Group Plc repurchase of own shares on 18.03.2026
MiTIETOEVRY OYJ: Tieto: Share repurchases on 18.3.2026
MiRAUTE OYJ: Raute Corporation: SHARE REPURCHASE 18.3.2026
MiAker Solutions ASA: Aker Solutions proposes NOK 3.60 ordinary dividend
MiAKELIUS RESIDENTIAL PROPERTY AB: Akelius issues EUR bond
MiVOLVO CAR: Volvo Cars recognised as a world leader in software-defined cars
MiNGM LISTING NOTICE: #26-99 Delisting of Derivatives from NGM
MiTELE2 AB: Issue and repurchase of class C shares for incentive program
MiNGM LISTING NOTICE: #26-98 Listing of Derivatives at NGM
MiNotice to attend the annual general meeting of Plejd AB
MiNOTICE OF ANNUAL GENERAL MEETING IN EVOLUTION AB (PUBL)
MiAHLSELL AB: Ahlsell acquires Luxia AS
MiUpdate on Evolution's capital allocation for 2026
MiLANCASHIRE HOLDINGS LIMITED: Director/PDMR Shareholding - RSS Awards
MiSecuritas completes acquisition of Liferaft
MiAllocation of NKT shares to Executive and subsequent transaction
MiAqilion sharpens focus on AQ280 and AQ128 - ready for the next phase in inflammatory diseases